Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest late-stage melanoma Stories

2013-07-29 08:25:43

Company Reports Strong Interim Data in Phase 2 Study Targeting Late-Stage Melanoma; Full Recruitment Expected by End of 2013 SYDNEY, July 29, 2013 /PRNewswire/ -- Viralytics Limited (ASX: VLA; OTC: VRACY), an oncolytic virotherapy company developing new drugs to treat a wide range of cancers, today announced that progress in its Phase 2 clinical trial of intratumourally administered CAVATAK(TM) for the treatment of late-stage melanoma (the CALM study) continues to accelerate with...

f2d1d174e9ad266b2a3df2720b6258b21
2011-03-26 08:45:00

A drug from Bristol-Myers Squibb Co. shown to help prolong the lives of people suffering from advanced skin cancer has been approved by the US Food and Drug Administration on Friday.The injectable drug, called Yervoy (ipilimumab), is used for late-stage melanoma. Bristol-Myers Squibb aims to use the drug to harness the body's immune system to target and attack melanoma tumors."Yervoy is the first therapy approved by the FDA to clearly demonstrate that patients with metastatic melanoma live...